Treatment of atopic eczema with oral myc
โ
K. Neuber; I. Schwartz; G. Itschert; A.tom Dieck
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 348 KB
## Background: Activated t and b lymphocytes are the predominant inflammatory cells in atopic eczema (ae) lesions. mycophenolic acid, the active form of mycophenolate mofetil (mmf), blocks the proliferative responses of t and b lymphocytes. ## Objectives: In this pilot study, we examined the effi